Piergentili, R.; Marinelli, E.; Cucinella, G.; Lopez, A.; Napoletano, G.; Gullo, G.; Zaami, S.
Correction: Piergentili et al. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA 2024, 10, 16. Non-Coding RNA 2025, 11, 50.
https://doi.org/10.3390/ncrna11040050
AMA Style
Piergentili R, Marinelli E, Cucinella G, Lopez A, Napoletano G, Gullo G, Zaami S.
Correction: Piergentili et al. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA 2024, 10, 16. Non-Coding RNA. 2025; 11(4):50.
https://doi.org/10.3390/ncrna11040050
Chicago/Turabian Style
Piergentili, Roberto, Enrico Marinelli, Gaspare Cucinella, Alessandra Lopez, Gabriele Napoletano, Giuseppe Gullo, and Simona Zaami.
2025. "Correction: Piergentili et al. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA 2024, 10, 16" Non-Coding RNA 11, no. 4: 50.
https://doi.org/10.3390/ncrna11040050
APA Style
Piergentili, R., Marinelli, E., Cucinella, G., Lopez, A., Napoletano, G., Gullo, G., & Zaami, S.
(2025). Correction: Piergentili et al. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. Non-Coding RNA 2024, 10, 16. Non-Coding RNA, 11(4), 50.
https://doi.org/10.3390/ncrna11040050
